
Stuart Snyder
Examiner (ID: 19177)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1648 |
| Total Applications | 524 |
| Issued Applications | 295 |
| Pending Applications | 33 |
| Abandoned Applications | 200 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10452348
[patent_doc_number] => 20150337362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'METHOD FOR THE SPECIFIC ISOLATION OF NUCLEIC ACIDS OF INTEREST'
[patent_app_type] => utility
[patent_app_number] => 14/758669
[patent_app_country] => US
[patent_app_date] => 2014-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7153
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14758669
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/758669 | Method for the specific isolation of nucleic acids of interest | Jan 26, 2014 | Issued |
Array
(
[id] => 9615764
[patent_doc_number] => 20140205622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'VACCINES AGAINST INFLUENZA VIRUS'
[patent_app_type] => utility
[patent_app_number] => 14/157417
[patent_app_country] => US
[patent_app_date] => 2014-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22877
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14157417
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/157417 | VACCINES AGAINST INFLUENZA VIRUS | Jan 15, 2014 | Abandoned |
Array
(
[id] => 9671835
[patent_doc_number] => 20140235699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'ADENO-PARVOVIRUS CHIMERA WITH ENHANCED ONCOLYTICAL POTENTIAL'
[patent_app_type] => utility
[patent_app_number] => 14/148114
[patent_app_country] => US
[patent_app_date] => 2014-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 13489
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14148114
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/148114 | Adeno-parvovirus chimera with enhanced oncolytical potential | Jan 5, 2014 | Issued |
Array
(
[id] => 10467450
[patent_doc_number] => 20150352465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'Chromatography Media For Purifying Vaccines And Viruses'
[patent_app_type] => utility
[patent_app_number] => 14/759426
[patent_app_country] => US
[patent_app_date] => 2014-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8182
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14759426
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/759426 | Chromatography Media For Purifying Vaccines And Viruses | Jan 2, 2014 | Abandoned |
Array
(
[id] => 9448957
[patent_doc_number] => 20140120126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'COMPOSITIONS OF HSP60 PEPTIDES AND VIRAL ANTIGENS FOR VACCINATION AND DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 14/146549
[patent_app_country] => US
[patent_app_date] => 2014-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 21469
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14146549
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/146549 | COMPOSITIONS OF HSP60 PEPTIDES AND VIRAL ANTIGENS FOR VACCINATION AND DIAGNOSIS | Jan 1, 2014 | Abandoned |
Array
(
[id] => 9568657
[patent_doc_number] => 20140186370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'VACCINIA VIRUS H3L AND B5R SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/142520
[patent_app_country] => US
[patent_app_date] => 2013-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 38890
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14142520
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/142520 | Vaccinia virus H3L and B5R specific monoclonal antibodies and methods of making and using same | Dec 26, 2013 | Issued |
Array
(
[id] => 9418325
[patent_doc_number] => 20140102975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'PROCESS FOR REDUCING BIO-CORROSION IN WATER SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 14/133115
[patent_app_country] => US
[patent_app_date] => 2013-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8841
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14133115
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/133115 | PROCESS FOR REDUCING BIO-CORROSION IN WATER SYSTEMS | Dec 17, 2013 | Abandoned |
Array
(
[id] => 11236181
[patent_doc_number] => 09462810
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-11
[patent_title] => 'Method for inactivating viruses with slightly acidic arginine'
[patent_app_type] => utility
[patent_app_number] => 14/108502
[patent_app_country] => US
[patent_app_date] => 2013-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7056
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14108502
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/108502 | Method for inactivating viruses with slightly acidic arginine | Dec 16, 2013 | Issued |
Array
(
[id] => 10428980
[patent_doc_number] => 20150313991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-05
[patent_title] => 'VACCINATION ADJUVANT, PREPARATION AND VACCINES CONTAINING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/651093
[patent_app_country] => US
[patent_app_date] => 2013-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9299
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14651093
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/651093 | VACCINATION ADJUVANT, PREPARATION AND VACCINES CONTAINING THE SAME | Dec 8, 2013 | Abandoned |
Array
(
[id] => 10416037
[patent_doc_number] => 20150301047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'METHOD FOR RECOGNITION OF A PRESENCE OF AN INFECTION WITH CMV'
[patent_app_type] => utility
[patent_app_number] => 14/646767
[patent_app_country] => US
[patent_app_date] => 2013-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 1685
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14646767
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/646767 | METHOD FOR RECOGNITION OF A PRESENCE OF AN INFECTION WITH CMV | Nov 24, 2013 | Abandoned |
Array
(
[id] => 10391757
[patent_doc_number] => 20150276764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'DETERMINING DISEASE STATES USING BIOMARKER PROFILES'
[patent_app_type] => utility
[patent_app_number] => 14/440869
[patent_app_country] => US
[patent_app_date] => 2013-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10061
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14440869
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/440869 | DETERMINING DISEASE STATES USING BIOMARKER PROFILES | Nov 4, 2013 | Abandoned |
Array
(
[id] => 11859014
[patent_doc_number] => 09738688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-22
[patent_title] => 'HIV-1 envelope glycoprotein'
[patent_app_type] => utility
[patent_app_number] => 14/072209
[patent_app_country] => US
[patent_app_date] => 2013-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 35
[patent_no_of_words] => 45881
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14072209
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/072209 | HIV-1 envelope glycoprotein | Nov 4, 2013 | Issued |
Array
(
[id] => 10892729
[patent_doc_number] => 08916341
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-12-23
[patent_title] => 'Methods for improving analyte detection using photochemical reactions'
[patent_app_type] => utility
[patent_app_number] => 14/071287
[patent_app_country] => US
[patent_app_date] => 2013-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 28
[patent_no_of_words] => 15269
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14071287
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/071287 | Methods for improving analyte detection using photochemical reactions | Nov 3, 2013 | Issued |
Array
(
[id] => 9334341
[patent_doc_number] => 20140061123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'Prevention and Remediation of Petroleum Reservoir Souring and Corrosion by Treatment with Virulent Bacteriophage'
[patent_app_type] => utility
[patent_app_number] => 14/060297
[patent_app_country] => US
[patent_app_date] => 2013-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11333
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14060297
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/060297 | Prevention and remediation of petroleum reservoir souring and corrosion by treatment with virulent bacteriophage | Oct 21, 2013 | Issued |
Array
(
[id] => 10219473
[patent_doc_number] => 20150104466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'CYTOMEGALOVIRUS DISINTEGRIN-LIKE PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/055299
[patent_app_country] => US
[patent_app_date] => 2013-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 13365
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14055299
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/055299 | CYTOMEGALOVIRUS DISINTEGRIN-LIKE PEPTIDES | Oct 15, 2013 | Abandoned |
Array
(
[id] => 9512091
[patent_doc_number] => 20140148581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-29
[patent_title] => 'NOVEL HA BINDING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/051405
[patent_app_country] => US
[patent_app_date] => 2013-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 79204
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14051405
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/051405 | HA binding agents | Oct 9, 2013 | Issued |
Array
(
[id] => 10414657
[patent_doc_number] => 20150299667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'INFLUENZA VIRUS AND TYPE 1 DIABETES'
[patent_app_type] => utility
[patent_app_number] => 14/435016
[patent_app_country] => US
[patent_app_date] => 2013-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 26117
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435016
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/435016 | INFLUENZA VIRUS AND TYPE 1 DIABETES | Oct 9, 2013 | Abandoned |
Array
(
[id] => 10380722
[patent_doc_number] => 20150265729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'ROD-SHAPED PLANT VIRUS NANOPARTICLES AS IMAGING AGENT PLATFORMS'
[patent_app_type] => utility
[patent_app_number] => 14/434435
[patent_app_country] => US
[patent_app_date] => 2013-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14463
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14434435
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/434435 | Rod-shaped plant virus nanoparticles as imaging agent platforms | Oct 8, 2013 | Issued |
Array
(
[id] => 12211051
[patent_doc_number] => 09907843
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-06
[patent_title] => 'Recombinant novirhabdovirus usable as an antigen vector'
[patent_app_type] => utility
[patent_app_number] => 14/435981
[patent_app_country] => US
[patent_app_date] => 2013-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 4020
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435981
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/435981 | Recombinant novirhabdovirus usable as an antigen vector | Oct 7, 2013 | Issued |
Array
(
[id] => 9338374
[patent_doc_number] => 20140065156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'HUMAN BINDING MOLECULES CAPABLE OF NEUTRALIZING INFLUENZA VIRUS H5N1 AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/043677
[patent_app_country] => US
[patent_app_date] => 2013-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 34786
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14043677
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/043677 | Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof | Sep 30, 2013 | Issued |